Peptide record

TPDB18951

Antibacterial Antiviral Toxicity standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB18951
Antibacterial Antiviral Toxicity
Anti-infective peptides Toxicity and safety peptides
Peptipedia
standard
No
A 21-aa standard-residue multi-activity (Antibacterial, Antiviral, and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
FARLQFTYNHIQRHVRDMEGR
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C117H180N40O31S1
CKPSW
R
2675.03
11.00
6
2
8
+2
3.81
-1.071
55.71
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
1490
0.56
5
Residue Composition
number
1
A
4
R
1
N
1
D
0
C
1
E
2
Q
1
G
2
H
1
I
1
L
0
K
1
M
2
F
0
P
0
S
1
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 1 R: 4 N: 1 D: 1 C: 0 E: 1 Q: 2 G: 1 H: 2 I: 1 L: 1 K: 0 M: 1 F: 2 P: 0 S: 0 T: 1 W: 0 Y: 1 V: 1
Chemical Descriptors
21 reviewed residue count
C117H180N40O31S1 sequence-only estimate (linear, free termini)
2675.03 sequence-only estimate (linear, free termini)
11.00 sequence-only estimate (linear, free termini)
+2 sequence-only estimate (linear, free termini)
3.81 sequence-only estimate (linear, free termini)
-1.071 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Activity

Toxicity
Cytotoxic
NA | target cell: Vero cells

Target

Vero cells

Source & Reference

NA
DBAASP
Conformational modifications of gB from herpes simplex virus type 1 analyzed by synthetic peptides. | J Med Chem | 2013